New York, New York 10021

  • Macular Degeneration

Purpose:

The purpose of this study is to provide compassionate use of anecortave acetate sterile suspension of 15 mg for a series of five patients as a means to control classic neovascularization following failure of treatment with photodynamic therapy using Visudyne.


Criteria:

Inclusion Criteria: 1. Clinical diagnosis of patients that previously had a failure of treatment with photodynamic therapy using Visudyne. 2. Patients must be at least 50 years of age. 3. Visual acuity of 20/30 to 20/320 in study eye on the Early Treatment of Diabetic Retinopathy Study (ETDRS) visual acuity chart 4. Visual acuity of 20/800 or better in fellow eye on the ETDRS visual acuity chart Exclusion Criteria: 1. Patient with significantly compromised visual acuity in the study eye due to concomitant ocular conditions. 2. Patients who have undergone intraocular surgery within the last 2 months. 3. Patient participating in any other investigational drug study. 4. Use of an investigational drug or treatment related or unrelated to their condition within 30 days prior to receipt of study medication. 5. Inability to obtain photographs to document choroidal neovascularization (CNV) (including difficulty with venous access). 6. Patient with significant liver disease or uremia. 7. Patient with known adverse reaction to fluorescein and indocyanine green or iodine. 8. Patient has a history of any medical condition which would preclude scheduled visits or completion of study 9. Patient has had insertion of scleral buckle in the study eye 10. Patient has received radiation treatment 11. Patient is on anticoagulant therapy with the exception of aspirin 12. Patient is pregnant or nursing.


NCT ID:

NCT00211458


Primary Contact:

Principal Investigator
Jason S Slakter, MD
Manhattan Eye, Ear & Throat Hospital


Backup Contact:

N/A


Location Contact:

New York, New York 10021
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: March 26, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.